Wykon Gan Mao Tea
Wykon Gan Mao Tea : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Camellia sinensis | Camellia sinensis[1200;mg;8000;mg] | Not identified |
| Rhizoma Phragmites Communis | Rhizoma Phragmites Communis[400;mg;8000;mg] | Not identified |
| radix angelica dahurica | radix angelica dahurica[320;mg;8000;mg] | Not identified |
| Herba schizonepeta tenuifolia | Herba schizonepeta tenuifolia[480;mg;8000;mg] | Not identified |
| HERBA MENTHA ARVENSIS | HERBA MENTHA ARVENSIS[640;mg;8000;mg] | Not identified |
| Herba Lophatherum Gracile | Herba Lophatherum Gracile[480;mg;8000;mg] | Not identified |
| Radix platycodon grandiflorum | Radix platycodon grandiflorum[640;mg;8000;mg] | Not identified |
| Fructus Forsythia Suspensa | Fructus Forsythia Suspensa[960;mg;8000;mg] | Not identified |
| Radix Scrophularia Ningpoensis | Radix Scrophularia Ningpoensis[400;mg;8000;mg] | Not identified |
| FLOS LONICERA JAPONICA | FLOS LONICERA JAPONICA[960;mg;8000;mg] | Not identified |
| Radix Glycyrrhiza glabra | Radix Glycyrrhiza glabra[480;mg;8000;mg] | Not identified |
| Radix puerariae lobata | Radix puerariae lobata[400;mg;8000;mg] | Not identified |
| Arctium lappa L. | Arctium lappa L.[640;mg;8000;mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL04125521T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- WYKON MEDICAL SDN. BHD.
- Manufacturer
- WAN YEEN TRADING SDN. BHD.
- Registration period starting
- 2026-01-09
- Published validity end
- 2031-01-09
Original register data
View published fields and their variants
- Active ingredients
- Camellia sinensis[1200;mg;8000;mg],Rhizoma Phragmites Communis[400;mg;8000;mg],radix angelica dahurica[320;mg;8000;mg],Herba schizonepeta tenuifolia[480;mg;8000;mg],HERBA MENTHA ARVENSIS[640;mg;8000;mg],Herba Lophatherum Gracile[480;mg;8000;mg],Radix platycodon grandiflorum[640;mg;8000;mg],Fructus Forsythia Suspensa[960;mg;8000;mg],Radix Scrophularia Ningpoensis[400;mg;8000;mg],FLOS LONICERA JAPONICA[960;mg;8000;mg],Radix Glycyrrhiza glabra[480;mg;8000;mg],Radix puerariae lobata[400;mg;8000;mg],Arctium lappa L.[640;mg;8000;mg]
- Valid until
- 2031-01-09
- Registration date
- 2026-01-09
- Published description
- NATURAL PRODUCT
- Licence holder
- WYKON MEDICAL SDN. BHD.
- Producer
- WAN YEEN TRADING SDN. BHD.
- Published name
- Wykon Gan Mao Tea
- Published reference
- 2004020319828
- Registration number
- MAL04125521T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL04125521T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Arctium lappa L.
Read the warning, when it applies and the studies cited
Burdock - Arctium Lappa - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are pregnant (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
Health Canada monograph dated 19 December 2025
BURDOCK - ARCTIUM LAPPA - Topical
Cautions and warnings
For external use only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Wykon Gan Mao Tea”, https://compoatlas.com/en/supplements/malaysia/MAL04125521T-wykon-gan-mao-tea, updated 27 October 2026.